Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7–9, 2010

Appendix

The co-authors of NIBIT are as follows: Luigi Aurisicchio—Takis, Rome, Italy; Andrea Balsari—University of Milan, Milan, Italy; Philipp Beckhove—German Cancer Research Center, Heidelberg, Germany; Matteo Bellone—San Raffaele Scientific Institute, Milan, Italy; Sergio Bracarda—San Donato Hospital, Arezzo, Italy; Luana Calabrò—University Hospital of Siena, Siena, Italy; Arianna Calcinotto—San Raffaele Scientific Institute, Milan, Italy; Federica Cavallo—University of Torino, Torino, Italy; Maria Ines Colnaghi—AIRC, Milan, Italy; Piero Dalerba—Stanford University, Palo Alto, USA; Riccardo Danielli—University Hospital of Siena, Siena, Italy; Anna Maria Di Giacomo—University Hospital of Siena, Siena, Italy; Silvano Ferrini—National Institute for Cancer Research, Genoa, Italy; Pier Francesco Ferrucci—European Institute of Oncology, Milan, Italy; Gilberto Filaci—University of Genoa and Genovax s.r.l, Genoa, Italy; Leonardo Giovannoni—Philogen, Siena, Italy; Ramy Ibrahim—Cancer Immunotherapy Consortium, USA; Pierluigi Lollini—University of Bologna, Bologna, Italy; Lucio Luzzatto—Istituto Toscano Tumori, Florence, Italy; Cristina Maccalli—San Raffaele Scientific Institute, Milan, Italy; Lina Matera—University of Turin and Molinette Hospital, Turin, Italy; Michela Perego—National Cancer Institute, Milan, Italy; Gabriella Pietra—University of Genoa, Genoa, Italy; Lorenzo Pilla—San Raffaele Scientific Institute, Milan, Italy; Enrico Proietti—Istituto Superiore di Sanità, Rome, Italy; Angela Santoni—Sapienza University of Rome, Rome, Italy; Barbara Stecca—Istituto Toscano Tumori, Florence, Italy; Licia Rivoltini—National Cancer Institute, Milan, Italy; Sjoerd H. van der Burg—Leiden University Medical Center, Leiden, The Netherlands.